Amyloidosis-associated kidney disease
- PMID: 17093068
- DOI: 10.1681/ASN.2006050460
Amyloidosis-associated kidney disease
Abstract
The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The kidney is one of the most frequent sites of amyloid deposition in AL, AA, and several of the hereditary amyloidoses. Amyloid fibril formation begins with the misfolding of an amyloidogenic precursor protein. The misfolded variants self-aggregate in a highly ordered manner, generating protofilaments that interact to form fibrils. The fibrils have a characteristic appearance by electron microscopy and generate birefringence under polarized light when stained with Congo red dye. Advances in elucidating the mechanisms of amyloid fibril formation, tissue deposition, and tissue injury have led to new and more aggressive treatment approaches for these disorders. This article reviews the pathogenesis, diagnosis, clinical manifestations, and treatment of the amyloidoses, focusing heavily on the renal aspects of each of these areas.
Similar articles
-
[Renal amyloidosis].Przegl Lek. 2013;70(4):205-10. Przegl Lek. 2013. PMID: 23991559 Review. Polish.
-
Hereditary systemic amyloidosis with renal involvement.J Nephrol. 2003 May-Jun;16(3):443-8. J Nephrol. 2003. PMID: 12832750 Review.
-
[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].Ital Heart J Suppl. 2002 Jun;3(6):590-7. Ital Heart J Suppl. 2002. PMID: 12116807 Review. Italian.
-
[Advances in diagnosis and treatment of AL amyloidosis].Pol Merkur Lekarski. 2008 Apr;24(142):340-5. Pol Merkur Lekarski. 2008. PMID: 18634370 Review. Polish.
-
Pathogenesis, diagnosis and treatment of systemic amyloidosis.Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):203-10; discussion 210-1. doi: 10.1098/rstb.2000.0766. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11260801 Free PMC article. Review.
Cited by
-
A Rare Case of Renal AA Amyloidosis Secondary to Sjogren's Syndrome.Eur J Case Rep Intern Med. 2019 Sep 16;6(9):001226. doi: 10.12890/2019_001226. eCollection 2019. Eur J Case Rep Intern Med. 2019. PMID: 31583215 Free PMC article.
-
Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center.Int J Nephrol. 2022 Jul 18;2022:8493479. doi: 10.1155/2022/8493479. eCollection 2022. Int J Nephrol. 2022. PMID: 35898389 Free PMC article.
-
A brief overview of amyloids and Alzheimer's disease.Protein Sci. 2014 Oct;23(10):1315-31. doi: 10.1002/pro.2524. Epub 2014 Jul 30. Protein Sci. 2014. PMID: 25042050 Free PMC article. Review.
-
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update.Diagnostics (Basel). 2024 Dec 23;14(24):2892. doi: 10.3390/diagnostics14242892. Diagnostics (Basel). 2024. PMID: 39767252 Free PMC article. Review.
-
Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report.Int Urol Nephrol. 2013 Apr;45(2):591-4. doi: 10.1007/s11255-012-0124-1. Epub 2012 Jan 20. Int Urol Nephrol. 2013. PMID: 22261745
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical